How Moderna's New mRNA Cancer Vaccine Works The latest development in cancer treatment, personalized mRNA vaccines, has generated significant excitement among medical professionals and patients.
A recent phase three trial of Moderna's intismeran vaccine showed promising results, extending the length of time a patient is cancer free.
One of the key advantages of these vaccines is their ability to tailor treatment to an individual's unique genetic profile.